☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
New Zealand
BioFactura Initiates P-I Study of BFI-751 (biosimilar- ustekinumab) in Australia and New Zealand
May 26, 2021
Glaukos Expands its Partnership with Santen for Preserflo MicroShunt
May 19, 2021
Cipla Expands its Partnership with Alvotech to Commercialize Biosimilars in Australia and New Zealand
March 2, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.